Floatz logo

Hyperpolarized [1-13C] Pyruvate Component (1-<Sup>13</Sup>C)-Pyruvic Acid

Prostate Cancer

Ivan de Kouchkovsky, MDSmall moleculePhase 2Active
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
59/ 100

Competitive context

481 Active assets in the Prostate Cancer cohort.

Asset / SponsorPhaseRating
Avodart
Bay State Clinical Trials, Inc.
Phase 4BBB
Desflurane
Peter MacCallum Cancer Centre, Australia
Phase 4BBB
Propofol
Peter MacCallum Cancer Centre, Australia
Phase 4BBB
Degarelix
Bayer
Phase 4BBB
Flotufolastat F 18
Washington University School of Medicine
Phase 4BB

View all 50 →

Same molecule, other indications

Hyperpolarized [1-13C] Pyruvate Component (1-<Sup>13</Sup>C)-Pyruvic Acid is also rated in:

prostate carcinomaActive
B
Indicative · Phase 2
60 / 100
View asset →
relapsing-remitting multiple sclerosisActive
CCC
Indicative · Phase 2
53 / 100
View asset →
female reproductive organ cancerActive
CCC
Indicative · Phase 2
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →